West Pharmaceutical Services, Inc. Stock
Stocks
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
16:00:03 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 412.62 USD | -0.97% |
|
+5.22% | +49.97% |
| 10-30 | Stephens Adjusts West Pharmaceutical Services Price Target to $490 From $450 | MT |
| 10-30 | Deutsche Bank Adjusts West Pharmaceutical Services PT to $450 From $420, Maintains Buy Rating | MT |
| Market Cap | 28.74B 25.74B 23.68B 21.46B 40.11B 2,729B 40.86B 282B 113B 1,436B 108B 106B 4,528B | P/E 2026 * |
48.1x | P/E 2027 * | 40.1x |
|---|---|---|---|---|---|
| Enterprise Value | 28.24B 25.3B 23.27B 21.08B 39.41B 2,682B 40.15B 277B 111B 1,411B 106B 104B 4,449B | EV / Sales 2026 * |
8.26x | EV / Sales 2027 * | 7.7x |
| Free-Float |
91.94% | Yield 2026 * |
0.23% | Yield 2027 * | 0.25% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| WST | Delayed | |
CBOE
| WST | Real-time | |
|
London S.E.
| 0ADY | Delayed | |
|
Boerse Muenchen
| WPS | Real-time | |
|
Tradegate
| WPS | Real-time | |
|
Deutsche Boerse AG
| WPS | Delayed | |
|
Börse Stuttgart
| WPS | Delayed | |
|
Berne S.E.
| WPS | End-of-day quote | |
|
Borsa Italiana
| 1WST | End-of-day quote |
Last Transcript: West Pharmaceutical Services, Inc.
| 1 day | -0.97% | ||
| 1 week | +5.22% | ||
| 1 month | +11.29% | ||
| 3 months | +21.02% | ||
| 6 months | +38.65% | ||
| Current year | +49.97% |
| 1 week | 388.06 |  | 438.27 |
| 1 month | 359.49 | | 438.27 |
| Current year | 223.83 | | 438.27 |
| 1 year | 223.83 | | 438.27 |
| 3 years | 187.43 | | 438.27 |
| 5 years | 187.43 | | 475 |
| 10 years | 73.69 | | 475.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michel Lagarde
CEO | Chief Executive Officer | 52 | 2026-08-30 |
Robert McMahon
DFI | Director of Finance/CFO | 57 | 2025-08-03 |
Devesh Mathur
CTO | Chief Tech/Sci/R&D Officer | - | 2025-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Buthman
BRD | Director/Board Member | 65 | 2011-01-31 |
Douglas Michels
BRD | Director/Board Member | 69 | 2011-03-06 |
William Feehery
BRD | Director/Board Member | 56 | 2012-02-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/30/26 | Other | Director | 44 | 0.0001% | ||
| 9/15/26 | Exercice | Head of Human Resources | 7,572 | 0.0108% | ||
| 9/8/26 | Free | Chief Executive Officer | 51,798 | 0.0736% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.97% | +5.22% | +46.28% | +29.64% | 28.74B | |
| +1.56% | +2.41% | -14.09% | +12.32% | 184B | |
| -0.59% | +1.18% | +6.44% | +36.82% | 118B | |
| -6.38% | -4.98% | -18.07% | +8.01% | 111B | |
| +3.42% | +1.71% | -41.92% | +8.01% | 94.58B | |
| +0.09% | -0.05% | -2.06% | +78.69% | 63.13B | |
| -0.46% | +0.42% | +4.48% | +82.84% | 55.66B | |
| -0.23% | -0.52% | +10.73% | -21.72% | 53.9B | |
| -4.30% | -1.64% | -12.44% | +37.99% | 43.42B | |
| +0.58% | +2.00% | -1.17% | -8.82% | 34.68B | |
| Average | -0.73% | +0.58% | -2.18% | +26.38% | 78.72B | |
| Weighted average by Cap. | -0.50% | +0.42% | -8.07% | +23.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.42B 3.06B 2.82B 2.55B 4.77B 325B 4.86B 33.61B 13.49B 171B 12.84B 12.57B 539B | 3.63B 3.25B 2.99B 2.71B 5.06B 344B 5.15B 35.63B 14.3B 181B 13.61B 13.32B 571B |
| Net income | 666M 596M 549M 497M 929M 63.22B 946M 6.54B 2.63B 33.26B 2.5B 2.45B 105B | 730M 653M 601M 545M 1.02B 69.27B 1.04B 7.17B 2.88B 36.44B 2.74B 2.68B 115B |
| Net Debt | -499M -447M -411M -372M -696M -47.35B -709M -4.9B -1.97B -24.91B -1.87B -1.83B -78.55B | -836M -749M -689M -624M -1.17B -79.36B -1.19B -8.21B -3.3B -41.74B -3.14B -3.07B -132B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-30 | US$412.62 | -0.97% | 1,062,352 |
| 26-10-29 | US$416.67 | +3.23% | 1,873,145 |
| 26-10-28 | US$403.64 | +1.34% | 773,291 |
| 26-10-27 | US$398.29 | +0.90% | 790,686 |
| 26-10-26 | US$394.73 | +0.66% | 649,659 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- WST Stock
Select your edition
All financial news and data tailored to specific country editions
